Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02040857 |
Title | A Study of Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Dana-Farber Cancer Institute|Pfizer |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of California, San Francisco | San Francisco | California | 94115 | United States | Details | |
Indiana University Health Hospital | Indianapolis | Indiana | 46202 | United States | Details | |
Massachusetts General Hospital | Boston | Massachusetts | 02214 | United States | Details | |
Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | United States | Details | |
Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
MGH/North Shore Cancer Center | Danvers | Massachusetts | 01923 | United States | Details | |
DF/DWCC at Milford Regional Cancer Center | Milford | Massachusetts | 01757 | United States | Details | |
South Shore Hospital | Weymouth | Massachusetts | 02190 | United States | Details | |
Dana-Farber/New Hampshire Oncology-Hematology | Londonderry | New Hampshire | 03053 | United States | Details | |
University of Pennsylvania-Abramson Cancer Center | Philadelphia | Pennsylvania | 19104 | United States | Details |